A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 134 (1), 44-54
- https://doi.org/10.1016/s0002-8703(97)70105-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- IntroductionThe American Journal of Cardiology, 1995
- Safety and efficacy of epoprostenol in patients with severe congestive heart failureThe American Journal of Cardiology, 1995
- Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failureJournal of the American College of Cardiology, 1993
- Hemodynamic, Hormonal, and Renal Effects of the Prostacyclin Analogue Iloprost in Conscious Dogs With and Without Heart FailureJournal of Cardiovascular Pharmacology, 1990
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.Circulation, 1984
- Prostacyclin therapy in patients with congestive heart failureThe American Journal of Cardiology, 1982
- Heart Failure in OutpatientsNew England Journal of Medicine, 1982